Are benzodiazepines really anxiolytic?. Evidence from a 3D maze spatial navigation task

Behavioural Brain Research

Volumn 188, Issue 1, 2008, Pages 136-153

  Ennaceur, A ^a   Michalikova, S ^a   van Rensburg, R ^b   Chazot, P L ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Benzodiazepines; Construct validity; GABAA; Rats; Spatial navigation; Strains

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; DIAZEPAM;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; MALE; MAZE TEST; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CHLORDIAZEPOXIDE; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOTOR ACTIVITY; SPATIAL BEHAVIOR; SPECIES SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 38749136711     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.10.026     Document Type: Article

References (139)

1. Amsel A. Hippocampal function in the rat: cognitive mapping or vicarious trial and error?. Hippocampus 3 (1993) 251-256
2. Anastasi A. Psychological testing. 6th ed. (1988), Macmillan, New York
3. Baas J.M., Nugent M., Lissek S., Pine D.S., and Grillon C. Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology 161 (2002) 233-247
4. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res 73 (1996) 277-280
5. Balleine B., Ball J., and Dickinson A. Benzodiazepine-induced outcome revaluation and the motivational control of instrumental action in rats. Behav Neurosci 108 (1994) 573-589
6. Ban T.A. The role of serendipity in drug discovery. Dialogues Clin Neurosci 8 (2006) 335-344
7. Barbee J.G., Shear, Shader R.I., Greenblatt D.J., Kravitz H.M., and Weissman. Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. J Clin Psychiatry 54 (1993) 86-97
8. Basile A.S., Lippa A.S., and Skolnick P. Anxioselective anxiolytics: can less be more?. Eur J Pharmacol 500 (2004) 441-451
9. Belzung C., Le Guisquet A.M., and Crestani F. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice. Psychopharmacology 148 (2000) 24-32
10. Bert B., Fink H., Sohr R., and Rex A. Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacol Biochem Behav 70 (2001) 411-420
11. Bodnoff S.R., Suranyi-Cadotte B., Quirion R., and Meaney M.J. A comparison of the effects of diazepam versus several typical and atypical antidepressant drugs in an animal model of anxiety. Psychopharmacology 97 (1989) 277-279
12. Borsini F., Podhorna J., and Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants?. Psychopharmaccology 163 (2002) 121-141
13. Broekkamp C.L.E., Berendsen H.H.G., Jenck F., and Van Delft A.M.L. Animal models for anxiety and response to serotonergic drugs. Psychopathology 22 (1989) 2-12
14. Brown M.F. Does a cognitive map guide choices in the radial-arm maze?. J Exp Psychol Anim Behav Process 18 (1992) 56-66
15. Carvalho-Netto E.F., and Nunes-de-Souza R.L. Use of the elevated T-maze to study anxiety in mice. Behav Brain Res 148 (2004) 119-132
16. Chaouloff F., Durand M., and Mormede P. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav Brain Res 85 (1997) 27-35
17. Cooper S.J. Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes. Appetite 44 (2005) 133-150
18. Costa E., and Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. TIPS 17 (1996) 192-200
19. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white box: validation as a model of anxiety. Pharmacol Biochem Behav 32 (1989) 777-785
20. Coull J.T., Frith C.D., and Dolan R.J. Dissociating neuromodulatory effects of diazepam on episodic memory encoding and executive function. Psychopharmacology 145 (1999) 213-222
21. Crabbe J.C., Gallaher E.J., Cross S.J., and Belknap J.K. Genetic determinants of sensitivity to diazepam in inbred mice. Behav Neurosci 112 (1998) 668-677
22. Crawley J., and Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13 (1980) 167-170
23. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9 (1985) 37-44
24. Crawley J.N., and Davis L.G. Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull 8 (1982) 609-612
25. Cronbach L., and Meehl P. Construct validity in psychological tests. Psychol Bull 52 (1955) 281-302
26. Cryan J.F., Kelly P.H., Chaperon F., Gentsch C., Mombereau C., Lingenhoehl K., et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310 (2004) 952-963
27. Dalvi A., and Rodgers R.J. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacol Biochem Behav 62 (1999) 727-734
28. Dawson G.R., Crawford S.P., Collinson N., Iversen S.D., and Tricklebank M.D. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus-maze are confounded by increases in locomotor activity. Psychopharmacology 118 (1995) 316-323
29. De Boer S.F., Slangen J.L., and Van der Gugten J. Effects of buspirone and chlordiazepoxide on plasma catecholamine and corticosterone levels in stressed and nonstressed rats. Pharmacol Biochem Behav 38 (1991) 299-308
30. Delay J., and Deniker P. Le traitement des psychoses par une méthode neurolytique dérivée de l'hibernothérapie (Le 4560 R.P. utilisé seul. En cure prolongée et continue). CR Congrés Méd Alién Neurol France 50 (1952) 497-502
31. Dias R., Sheppard W.F.A., Fradley R.L., Garrett E.M., Stanley J.L., Tye S.J., et al. Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J Neurosci 25 (2005) 10682-10688
32. Domino E.F. History of modern psychopharmacology: a personal view with an emphasis on antidepressants. Psychosom Med 61 (1999) 591-598
33. Drapier D., Bentué-Ferrer D., Bruno Laviolle, Millet B., Allain H., Bourin M., et al. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 176 (2007) 202-209
34. Ellenbroek B.A., and Cools A.R. Animal models with construct validity for schizophrenia. Behav Pharmacol 1 (1990) 469-490
35. Ennaceur A., Michalikova S., and Chazot PL. Models of anxiety: responses of rats to novelty in an open space and an enclosed space. Behav Brain Res 171 (2006) 26-49
36. Ennaceur A., Michalikova S., van Rensburg R., and Chazot P.L. Models of anxiety: responses of mice to novelty and open spaces in a 3D maze. Behav Brain Res 174 (2006) 9-38
37. Ennaceur A., Michalikova S., van Rensburg R., and Chazot P.L. Detailed analysis of the behavior and memory performance of middle-aged male and female CD-1 mice in a 3D maze. Behav Brain Res 187 (2008) 312-326
38. Foster S.L., and Cone J.D. Validity issues in clinical assessment. Psychol Assess 7 (1995) 248-260
39. Fray P., and Robbins T.W. CANTAB battery: proposed utility in neurotoxicology. Neurotoxicol Teratol 18 (1996) 499-504
40. Garden S.E., and Coons E.E. Diazepam's impact on self-stimulation but not stimulation-escape suggests hedonic modulation. Behav Neurosci 104 (1990) 56-61
41. Geier F.M., Levin M., and Tolman E.C. Individual differences in emotionality, hypothesis formation, vicarious trial and error and visual discrimination learning in rats. Comp Psychol Monor 17 3 (1941)
42. Giersch A., and Herzog M.H. Lorazepam strongly prolongs visual information processing. Neuropsychopharmacology 29 (2004) 1386-1394
43. Graeff F.G., Ferreira Netto C., and Zangrossi Jr. H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23 (1998) 237-246
44. Graeff F.G., Viana M.B., and Mora P. Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 21 (1997) 791-799
45. Gray J.A., and McNaughton N. The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. 2nd ed. (2000), Oxford University Press, Oxford
46. Greenblatt D.J., Divoll M., Abernethy D.R., and Shader R.I. Benzodiazepine hypnotics: kinetic and therapeutic options. Sleep 5 (1982) 18-27
47. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65 (1995) 319-395
48. Griebel G., Belzung C., Perrault G., and Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology 148 (2000) 164-170
49. Groenink L., van der Gugten J., Zethof T.J.J., van der Heyden J.A.M., and Olivier B. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice. Pharmacol Biochem Behav 54 (1996) 249-253
50. Hascoet M., and Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 60 (1998) 645-653
51. Haynes S.N., Richard D.C.S., and Kubany E.S. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess 7 (1995) 238-247
52. Healy D. The antidepressant era (1999), Harvard University Press
53. Healy D. Psychopharmacological history through the looking glass of advancing years. In: Curran S., and Bullock R. (Eds). Practical old age psychopharmacology-a multi-professional approach (2005), Radcliffe Medical Press
54. Hodgson R.I., and Rachman S. Desynchrony in measures of fear. Behav Res Ther 12 (1974) 319-326
55. Hu D., and Amsel A. A simple test of the vicarious trial-and-error hypothesis of hippocampal function. Proc Natl Acad Sci USA 92 (1995) 5506-5509
56. Jackson L.L. V.T.E. on an elevated maze. J Comp Psychol 36 (1943) 99-107
57. Jacobson L.H., Bettler B., Kaupmann K., and Cryan J.F. Behavioral evaluation of mice deficient in GABAB(1) receptor isoforms in tests of unconditioned anxiety. Psychopharmacology 190 (2007) 541-553
58. Jenkins I.A., Playfor S.D., Bevan C., Davies G., and Wolf A.R. Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth 17 7 (2007) 675-683
59. Kay J., and Tasman A. The psychiatric interview: settings and techniques. In: Kay J., and Tasman A. (Eds). Essential of psychiatry (2006), John Wiley & Sons 30-50 [Chapter 3]
60. Keim K.L., and Sigg E.B. Plasma corticosterone and brain catecholamines in stress: effect of psychotrophic drugs. Pharmacol Biochem Behav 6 (1977) 79-85
61. Kendell R., and Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 160 (2003) 4-12
62. Kilfoil T., Michel A., Montgomery D., and Whiting R.L. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28 (1989) 901-905
63. King D.J. Benzodiazepines, amnesia and sedation: theoretical and clinical issues and controversies. Human Psychopharmacol 7 (1992) 79-87
64. Kopp C., Vogel E., and Misslin R. Comparative study of emotional behaviour in three inbred strains of mice. Behav Process 47 (1999) 161-174
65. Korpi E.R., and Sinkkonen S.T. GABAA receptor subtypes as targets for neuropsychiatric drug development. Pharmacol Ther 109 (2006) 12-32
66. Kovacs M., and Beck A.T. Maladaptive cognitive structures in depression. Am J Psychiat 135 (1978) 525-533
67. Kuznetsova .G., Amstislavskaya T.G., Bulygina V.V., Tibeikina M.A., and Popova N.K. Effect of 5HT2C-receptor agonist MK-212 on blood corticosterone level and behavior in mice. Bull Exp Biol Med 142 (2006) 594-597
68. Laborit H., and Huguenard P. L'hibernation artificielle par moyens pharmacodynamiques et physiques. Presse Médicale 59 (1951) 1329
69. Laborit H., Huguenard P., and Alluaume R. Un nouveau stabilisateur végétatif (le 4560 RP). Presse Médicale 60 (1952) 206-208
70. Lahti R.A., and Barsuhn C. The effect of minor tranquilizers on stress-induced increases in rat plasma corticosteroids. Psychopharmacologia 35 (1974) 215-220
71. Lahti R.A., and Barsuhn C. The effect of various doses of minor tranquilizers on plasma corticosteroids in stressed rats. Res Commun Chem Path Pharmacol 11 (1975) pp. 595-403
72. Landy F.J. Stamp collecting versus science: validation as hypothesis testing. Am Psychol 41 (1986) 1183-1192
73. Lapin I.P. The absence of reproducible effects from anxiolytics and anxiogens on the behavior of different strains of mice in a dark-light chamber. Eksp Klin Farmakol 55 (1992) 10-13
74. Lepicard E.M., Joubert C., Hagneau I., Perez-Diaz F., and Chapouthier G. Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice. Pharmacol Biochem Behav 67 (2000) 739-748
75. Lett B.T., Grant V.L., Neville L.L., Davis M.J., and Koh M.T. Chlordiazepoxide counteracts activity-induced suppression of eating in rats. Exp Clin Psychopharmacol 5 (1997) 24-27
76. Malcolm R.J. GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry 64 Suppl. 3 (2003) 36-40
77. Marc V., and Morselli P.L. Effect of diazepam on plasma corticosterone levels in the rat. J Pharm Pharmacol 21 (1969) 784-786
78. Marx C.E., Shampine L.J., Khisti R.T., Trost W.T., Bradford D.W., Grobin A.C., et al. Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions. Pharmacol Biochem Behav 84 (2006) 609-617
79. Matheson G.K., Gage D., White G., Dixon V., and Gipson D. A comparison of the effects of buspirone and diazepam on plasma corticosterone levels in rat. Neuropharmacology 27 (1988) 823-830
80. McElroy J.F., Fleming R.L., and Feldman R.S. A comparison between chlordiazepoxide and CL218,872-asynthetic nonbenzodiazepine ligand for benzodiazepine receptors on locomotor activity in rats. Psychopharmacology 85 (1985) 224-226
81. McElroy J.F., Miller J.M., and Meyer J.S. Comparison of the effects of chlordiazepoxide and CL 218, 872 on serum corticosterone concentrations in rats. Psychopharmacology (Berlin) 91 (1987) 467-472
82. McKernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype. Nat Neurosci 3 (2000) 587-592
83. Mechan A.O., Moran P.M., Elliott J.M., Young A.M.J., Joseph M.H., and Green A.R. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam. Psychopharmacology 159 (2002) 188-195
84. Merlis S., Tuner W.J., and Krumholz W. A double blind comparison of diazepam, chlordiazepoxide and chlorpromazine in psychotic patients. J Neuropsychiatry 3 (1962) S62-S67
85. Michael G.A., Bacon E., and Offerlin-Meyer I. Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias. J Psychopharmacol 21 (2007) 691-697
86. Michalikova S., Ennaceur A., van Rensburg R., and Chazot P.L. Behavior and memory performance of middle-aged female CD1 mice in a 3D maze: effects of near infrared light. Neurobiol Learn Mem (2007) 10.1016/j.nlm.2007.07.014
87. Mikkelsen J.D., Søderman A., Kiss A., and Mirza N. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. Eur J Pharmacol 519 (2005) 223-230
88. Millar K., Asbury A.J., Bowman A.W., Hosey M.T., Martin K., Musiello T., et al. A randomised placebo-controlled trial of the effects of midazolam premedication on children's postoperative cognition. Anaesthesia 62 9 (2007) 923-930
89. Mills D.S. Medical paradigms for the study of problem behaviour: a critical review. Appl Anim Behav Sci 81 (1983) 265-277
90. Mintzer M.Z., and Griffiths R.R. Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes. Exp Clin Psychopharmacol 11 (2003) 56-72
91. Möller H.J. Effectiveness and safety of benzodiazepines. J Clin Psychopharmacol 19 6 Suppl. 2 (1999) 2S-11S
92. Muenzinger K. Vicarious trial and error at a point of choice. I: A general survey of its relation of learning efficiency. J Gen Psychol 53 (1938) 75-86
93. Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med 2 2 (2006) S7-S11
94. Ohl F., Sillaber I., Binder E., Keck M.E., and Holsboer F. Differential analysis of behavior and diazepam-induced alterations in C57BL/6N and BALB/c mice using the modified hole board test. J Psychiatric Res 35 (2001) 147-154
95. Onaivi E.S., and Martin B.R. Neuropharmacological and physiological validation of a computer-controlled two compartment black and white box for the assessment of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 13 (1989) 963-976
96. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
97. Peterson L., Homer A.L., and Wonderlich S.A. The integrity of independent variables in behavior analysis. J Appl Behav Anal 15 (1982) 477-492
98. Pich E.M., and Samanin R. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat. Pharmacol Res 21 (1989) 595-602
99. Pound P., Ebrahim S., Sandercock P., Bracken M.B., and Roberts I. Where is the evidence that animal research benefits humans?. BMJ 328 (2004) 514-517
100. Primeaux S.D., Wilson S.P., McDonald A.J., Mascagni F., and Wilson M.A. The role of delta opioid receptors in the anxiolytic actions of benzodiazepines. Pharmacol Biochem Behav 85 (2006) 545-554
101. Quattrone C.A. On the congruity between internal states and action. Psychol Bull 98 (1985) 3-40
102. Rachman S., and Hodgson R. Synchrony and desynchrony in measures of fear and avoidance. Behav Res Ther 12 (1974) 311-318
103. Ramirez D.R., Buzzetti R.A., and Savage L.M. The role of the GABAA agonist muscimol on memory performance: reward contingencies determine the nature of the deficit. Neurobiol Learn Mem 84 (2005) 184-191
104. Ramos A., Berton O., Mormede P., and Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 85 (1997) 57-69
105. Rees W.L., and Healy D. The place of clinical trials in the development of psychopharmacology. Hist Psychiatry 8 (1997) 1-20
106. Rittenhouse P.A., Bakkum E.A., Levy A.D., Li Q., Carnes M., and van de Kar L.D. Evidence that ACTH secretion is regulated by serotonin 2A/2C (5-HT2A/2C) receptors. J Pharmacol Exp Ther 271 (1994) 1647-1655
107. Rivas-Vazquez R.A. Benzodiazepines in contemporary clinical practice. Prof Psychol: Res Prac 34 (2003) 324-328
108. Rocha B., Rigo M., di Scala G., Sandner G., and Hoyer D. Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels. Eur J Pharmacol 262 (1994) 125-131
109. Rodgers R.J., Davies B., and Shore R. Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes, Brain Behav 1 (2002) 242
110. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401 (1999) 796-800
111. Rudolph U., and Möhler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44 (2004) 475-498
112. Salinas J.A., Dickinson-Anson H., and McGaugh J.L. Midazolam administered to rats induces anterograde amnesia for changes in reward magnitude. Behav Neurosci 108 (1994) 1059-1064
113. Sanchez C., and Meier E. Behavioural profiles of SSRIs in animal models of depression, anxiety and aggression: are they all alike?. Psychopharmacology 129 (1997) 197-205
114. Schmidt M.V., and Müller M.B. Animal models of anxiety. Drug Discov Today: Dis Models 3 (2006) 369-374
115. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., and Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 116 (1994) 56-64
116. Shorter E. A history of psychiatry: from the era of asylum to the age of Prozac (1997), John Wiley and Sons, New York
117. Shorter E., and Tyrer P. Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease. Br Med J 327 (2003) 158-160
118. Silva R.C.B., and Brandão M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 65 (2000) 209-216
119. Sternbach L.H. The discovery of librium. Agents Actions 2 (1972) 193-196
120. Strekalova T., Spanagel R., Dolgov O., and Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 16 (2005) 171-180
121. Tang J., Wang B., White P.F., Gold M., and Gold J. Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures. Anesth Analg 89 4 (1999) 893-898
122. Tobin J.M., and Lewis N.D. New psychotherapeutic agent, chlordiazepoxide, use in the treatment of anxiety states and related symptoms. JAMA 174 (1960) 1242-1249
123. Tolman E.C. The determiners of behavior at a choice point. Psychol Rev 46 (1938) 318-336
124. Torrellas A., Guaza C., and Borrell J. Effects of acute and prolonged administration of chlordiazepoxide upon the pituitary-adrenal activity and brain catecholamines in sound stressed and unstressed rats. Neuroscience 5 (1980) 2289-2295
125. Treit D., Pesold C., and Rotzinger S. Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety. Behav Neurosci 107 (1993) 1099-1105
126. van de Kar L.D., Javed A., Zhang Y., Serres F., Raap D.K., and Gray T.S. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin expressing cells. J Neurosci 21 (2001) 3572-3579
127. van der Staay F.J. Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev 52 2006 (2006) 131-159
128. Vargas M.L., Abella C., and Hernandez J. Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 133 2001 (2001) 1355-1361
129. von Delius S., Hollweck R., Schmid R.M., and Frimberger E. Midazolam-pain, but one cannot remember it: a survey among Southern German endoscopists. Eur J Gastroenterol Hepatol 19 6 (2007) 465-470
130. Walsh T.J., McLamb R.L., and Tilson H.A. A comparison of the effects of RO15,1788 and chlordiazepoxide on hot-plate latencies, acoustic startle, and locomotor activity. Psychopharmacology 88 (1986) 514-519
131. Whiting P.J. GABA-A receptors: a viable target for novel anxiolytics?. Curr Opin Pharmacol 6 (2006) 24-29
132. Wicker A.W. Attitude versus action: the relationship of verbal and overt behavioral responses to attitude objects. J Social Sci 25 (1969) 41-68
133. Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuro-Psychopharmacol Biol Psychiatry 10 (1986) 677-690
134. Wilson M.A., Burghardt P.R., Ford K.A., Wilkinson M.B., and Primeaux S.D. Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females. Pharmacol Biochem Behav 78 (2004) 445-458
135. Wise R.A., and Dawson V. Diazepam-induced eating and lever pressing for food in sated rats. J Comp Physiol Psychol 86 (1974) 930-941
136. Young R., and Johnson D.N. A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40 (1991) 739-743
137. Zangrossi H., and Graeff F.G. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 44 (1997) 1-5
138. Carola V., D'Olimpio F., Brunamonti E., Mangia F., and Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res 134 (2002) 49-57
139. Miyata S., Shimoi T., Hirano S., Yamada N., Hata Y., Yoshikawa N., Ohsawa M., and Kamei J. Effects of serotonergic anxiolytics on the freezing behavior in the elevated open-platform test in mice. J Pharmacol Sci 105 (2007) 272-278